Medicare Enrolled

Dr. Ashley Desrocher, N.P.

Physician Assistant · Grand Rapids, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
100 MICHIGAN ST NE, Grand Rapids, MI 49503
6163912932
In practice since 2010 (16 years)
NPI: 1104147792 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Desrocher from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desrocher? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Desrocher

Dr. Ashley Desrocher is a physician assistant in Grand Rapids, MI, with 16 years of NPI registration. Based on federal Medicare data, Dr. Desrocher performed 216 Medicare services across 157 unique beneficiaries.

Between the years covered by Open Payments, Dr. Desrocher received a total of $6,853 from 38 pharmaceutical and/or device companies across 162 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Desrocher is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 39% volume in MI $6,853 industry payments

Medicare Practice Summary

Medicare Utilization ↗
216
Medicare services
Top 39% in MI for physician assistant
157
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~14 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
70 $36 $186
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
46 $78 $217
Gastric or small bowel dilation with tube
A procedure to widen the stomach or small intestine using a long gastrointestinal tube.
30 $13 $65
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
26 $10 $59
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
19 $60 $375
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
14 $8 $12
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
11 $15 $81
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
53.2% high complexity
5.1% medium
41.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,853
Total received (2021-2024)
Avg $1,713/year across 4 years
Top 2% in MI for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
162
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,839 (85.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,014 (14.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,541
2023
$2,247
2022
$1,278
2021
$1,787

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Chiesi USA, Inc.
$455
Janssen Scientific Affairs, LLC
$242
TG Therapeutics, Inc.
$203
Biogen, Inc.
$131
GlaxoSmithKline, LLC.
$131
Boehringer Ingelheim Pharmaceuticals, Inc.
$125
Novartis Pharmaceuticals Corporation
$76
IDORSIA PHARMACEUTICALS US INC
$74
AstraZeneca Pharmaceuticals LP
$64
Amgen Inc.
$22
Insmed, Inc.
$18
Top 3 companies account for 58.5% of 2024 payments
All-time payments by company (2021-2024) ›
Chiesi USA, Inc.
$1,014
GlaxoSmithKline, LLC.
$759
AstraZeneca Pharmaceuticals LP
$617
Grifols USA, LLC
$404
Boehringer Ingelheim Pharmaceuticals, Inc.
$363
Janssen Pharmaceuticals, Inc
$314
Genentech USA, Inc.
$276
Janssen Scientific Affairs, LLC
$264
Takeda Pharmaceuticals U.S.A., Inc.
$243
ABBVIE INC.
$241
Paratek Pharmaceuticals, Inc.
$207
TG Therapeutics, Inc.
$203
IDORSIA PHARMACEUTICALS US INC
$199
Biogen, Inc.
$181
TG THERAPEUTICS, INC.
$179
Alnylam Pharmaceuticals Inc.
$144
Novartis Pharmaceuticals Corporation
$130
Insulet Corporation
$129
AMAG Pharmaceuticals, Inc.
$118
Amgen Inc.
$115
Janssen Biotech, Inc.
$101
Lundbeck LLC
$98
Daiichi Sankyo Inc.
$71
SANOFI-AVENTIS U.S. LLC
$67
SCYNEXIS, Inc.
$60
GENZYME CORPORATION
$57
Alkermes, Inc.
$39
PFIZER INC.
$38
AbbVie Inc.
$35
Sandoz Inc.
$31
Alexion Pharmaceuticals, Inc.
$23
Fresenius Kabi USA, LLC
$22
Organon LLC
$20
Medtronic, Inc.
$20
Pharmacosmos Therapeutics Inc.
$19
La Jolla Pharmaceutical Company
$18
Insmed, Inc.
$18
American Regent
$15
Top 3 companies account for 34.9% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AMVUTTRA · AVSOLA · AVYCAZ · Actemra · Activase · Arikayce · BENLYSTA · BREZTRI · BRIUMVI · COSENTYX · CUVITRU · DALVANCE · ELFABRIO · ENTYVIO · EVENITY · FABRAZYME · FERAHEME · GATTEX · Gamunex-C · INFLECTRA · INJECTAFER · JARDIANCE · KRYSTEXXA · LUMIZYME · MAZOR X SYSTEM · MONOFERRIC · NUCALA · NUZYRA · OCREVUS · ONPATTRO · Omnipod · Prolastin-C Liquid · QUVIVIQ · RINVOQ · Rituxan · SAPHNELO · SKYRIZI · SOLIRIS · SPEVIGO · STELARA · Smoflipid · TREMFYA · TYSABRI · TZIELD · Tecentriq · VIVITROL · VPRIV · VYEPTI · XARELTO · XERAVA · Xembify · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (85%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for physician assistant in MI.

Looking for a physician assistant in Grand Rapids?
Compare physician assistants in the Grand Rapids area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
365
Per 100K population
55.4
County median income
$80,390
Nearest hospital
SPECTRUM HEALTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Desrocher is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 2% of MI peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Desrocher experienced with intravenous infusion, 1 hour or less?
Based on Medicare claims data, Dr. Desrocher performed 70 intravenous infusion, 1 hour or less services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Desrocher receive payments from pharmaceutical companies?
Yes. Dr. Desrocher received a total of $6,853 from 38 companies across 162 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Desrocher's costs compare to other physician assistants in Grand Rapids?
Dr. Desrocher's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Desrocher) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →